Identifying treatment options for triple negative breast cancer patients using RNA-sequencing.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.7_suppl.31
Abstract: 31Background: In the context of diagnostics, RNA is proxy for proteins and proteins are typically targets for drugs; e.g. breast cancer is typically driven by over-expression of various hormone receptors and Her2. In the current… read more here.
Keywords: breast cancer; identifying treatment; using rna; cancer patients ... See more keywords
Identifying treatment options for SCLC patients with multiplexed clinical proteomic testing.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.8574
Abstract: 8574Background: Even with standard platinum doublet therapy, most patients with small-cell lung cancer (SCLC) survive < 1 year. For those with refractory or relapsed disease, second-line, single-ag... read more here.
Keywords: treatment options; options sclc; identifying treatment; multiplexed clinical ... See more keywords